Cargando…
The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol
Breast cancer expressing the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) is known as triple-positive (TPBC). TPBC represents 9–11% of breast cancer cases worldwide and is a heterogeneous subtype. Notably, TPBC presents a therapeutic challeng...
Autores principales: | López-Méndez, José A., Ventura-Gallegos, José L., Camacho-Arroyo, Ignacio, Lizano, Marcela, Cabrera-Quintero, Alberto J., Romero-Córdoba, Sandra L., Martínez-Vázquez, Mariano, Jacobo-Herrera, Nadia J., León-Del-Río, Alfonso, Paredes-Villa, Adrian A., Zentella-Dehesa, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688505/ https://www.ncbi.nlm.nih.gov/pubmed/38034484 http://dx.doi.org/10.3892/ol.2023.14152 |
Ejemplares similares
-
In Vitro Cytotoxicity of Trastuzumab (Tz) and Se-Trastuzumab (Se-Tz) against the Her/2 Breast Cancer Cell Lines JIMT-1 and BT-474
por: Bapat, Priyanka, et al.
Publicado: (2021) -
Development and Characterization of Nanoliposomal Hydroxyurea Against BT-474 Breast Cancer Cells
por: Akbari, Azam, et al.
Publicado: (2020) -
Voltage-gated K(+) channels promote BT-474 breast cancer cell migration
por: Chow, Louis WC, et al.
Publicado: (2018) -
Design and Characterization of Liposomal Methotrexate and Its Effect on BT-474 Breast Cancer Cell Line
por: Tavakoli Dastjerd, Niloufar, et al.
Publicado: (2021) -
Effect of Sterols Isolated from Myrtillocactus geometrizans on Growth Inhibition of Colon and Breast Cancer Cells
por: Bolaños-Carrillo, Mario Augusto, et al.
Publicado: (2015)